These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8711682)
1. Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours. Beer TW; Rowlands DC; Crocker J Thorax; 1996 May; 51(5):526-9. PubMed ID: 8711682 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of multidrug resistance gene product, P-glycoprotein, in normal, dysplastic and malignant oral mucosa in India. Jain V; Das SN; Luthra K; Shukla NK; Ralhan R Int J Cancer; 1997 Feb; 74(1):128-33. PubMed ID: 9036881 [TBL] [Abstract][Full Text] [Related]
3. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. Charpin C; Vielh P; Duffaud F; Devictor B; Andrac L; Lavaut MN; Allasia C; Horschowski N; Piana L J Natl Cancer Inst; 1994 Oct; 86(20):1539-45. PubMed ID: 7932810 [TBL] [Abstract][Full Text] [Related]
4. Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer. Darnton SJ; Jenner K; Steyn RS; Ferry DR; Matthews HR J Clin Pathol; 1995 Nov; 48(11):1064-6. PubMed ID: 8543635 [TBL] [Abstract][Full Text] [Related]
5. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome. Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636 [TBL] [Abstract][Full Text] [Related]
6. Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma? Ashmore SM; Thomas DG; Darling JL Anticancer Drugs; 1999 Nov; 10(10):861-72. PubMed ID: 10630353 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of P-glycoprotein distribution in lung cancer. Pujol JL; Simony J; Gautier V; Marty-Ané C; Pujol H; Michel FB Lung Cancer; 1993 Oct; 10(1-2):1-12. PubMed ID: 7915180 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of multidrug resistance and P-glycoprotein expression in patients with gastric carcinoma. Fujii H; Tanigawa N; Muraoka R; Shimomatsuya T; Tanaka T J Surg Oncol; 1995 Jan; 58(1):63-9. PubMed ID: 7823576 [TBL] [Abstract][Full Text] [Related]
9. Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis. Soini Y; Virkajärvi N; Raunio H; Pääkkö P J Clin Pathol; 1996 Jun; 49(6):470-3. PubMed ID: 8763260 [TBL] [Abstract][Full Text] [Related]
10. Expression of multidrug resistance-associated P-glycoprotein in feline tumours. Van der Heyden S; Chiers K; Vercauteren G; Daminet S; Wegge B; Paepe D; Ducatelle R J Comp Pathol; 2011; 144(2-3):164-9. PubMed ID: 20880544 [TBL] [Abstract][Full Text] [Related]
11. Expression of P-glycoprotein, a multidrug-resistance gene product, is induced by radiotherapy in patients with oral squamous cell carcinoma. Ng IO; Lam KY; Ng M; Kwong DL; Sham JS Cancer; 1998 Sep; 83(5):851-7. PubMed ID: 9731886 [TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein as a prognostic indicator in pre- and postchemotherapy ovarian adenocarcinoma. Khalifa MA; Abdoh AA; Mannel RS; Walker JL; Angros LH; Min KW Int J Gynecol Pathol; 1997 Jan; 16(1):69-75. PubMed ID: 8986535 [TBL] [Abstract][Full Text] [Related]
13. Optimization of immunohistochemical detection of P-glycoprotein in chronic lymphoid disorders. Attal M; Bibeau F; Muller C; Duchayne E; Kuhlein E; Cassar G; Delsol G; Laurent G Am J Clin Pathol; 1994 Dec; 102(6):842-9. PubMed ID: 7801902 [TBL] [Abstract][Full Text] [Related]
14. Demonstration of MDR1 P-glycoprotein isoform expression in benign and malignant human prostate cells by isoform-specific monoclonal antibodies. Kawai K; Sakurai M; Sakai T; Misaki M; Kusano I; Shiraishi T; Yatani R Cancer Lett; 2000 Mar; 150(2):147-53. PubMed ID: 10704736 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of P-glycoprotein expression in human oral oncogenesis: correlation with clinicopathological features. Ralhan R; Narayan M; Salotra P; Shukla NK; Chauhan SS Int J Cancer; 1997 Sep; 72(5):728-34. PubMed ID: 9311585 [TBL] [Abstract][Full Text] [Related]
16. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis? Mongkonsritragoon W; Kimlinger T; Ahmann G; Greipp PR Leuk Lymphoma; 1998 May; 29(5-6):577-84. PubMed ID: 9643571 [TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein expression and multidrug resistance in cutaneous T-cell lymphoma. Jillella AP; Murren JR; Hamid KK; Longley BJ; Edelson RL; Cooper DL Cancer Invest; 2000; 18(7):609-13. PubMed ID: 11036468 [TBL] [Abstract][Full Text] [Related]
18. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein. Alexander D; Yamamoto T; Kato S; Kasai S Surg Today; 1999; 29(5):401-6. PubMed ID: 10333409 [TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase. Rao VV; Anthony DC; Piwnica-Worms D J Histochem Cytochem; 1995 Dec; 43(12):1187-92. PubMed ID: 8537634 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: relevance to indicator of better prognosis. Suwa H; Ohshio G; Arao S; Imamura T; Yamaki K; Manabe T; Imamura M; Hiai H; Fukumoto M Jpn J Cancer Res; 1996 Jun; 87(6):641-9. PubMed ID: 8766529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]